DOCUMENT 02 · AUGUST 2026
Executive Summary
EF Resonator — concise overview of the opportunity, development strategy, and requested investment.
The Opportunity
Develop a premium, programmable whole-body electromagnetic wellness and research platform built around documented output, repeatable protocols, careful claims, and a clear path from prototype to pilot deployment.
Problem & Solution
Existing electromagnetic-field products vary widely in engineering quality, controls, serviceability, and supporting evidence. Project Resonance proposes an integrated bed-format platform combining configurable field delivery, operator controls, session logging, safety systems, and research-ready protocol management.
Development Strategy
0–9 months: requirements, simulation, risk analysis, alpha prototype.
9–18 months: beta units, safety and usability testing, design iteration.
18–30 months: limited production, reference sites, pilot-readiness decision.
Initial Markets
Longevity, chiropractic, physical-therapy, and recovery clinics · premium gyms, sports-performance, and biohacking centers · universities, veterinary programs, and independent investigators.
Positioning & Evidence
The initial strategy is conservative: pursue general wellness positioning only after legal and regulatory review, while building device-specific evidence. Research partnerships and prospective studies would support any later regulated medical claims. No disease-treatment or cure claims are assumed.
Business Model
Preliminary planning assumes hardware sales in the $150,000–$250,000 range, leasing at $4,000–$8,000 monthly, and recurring service, software, and data-platform revenue. Pricing and adoption must be validated through engineering quotations and customer discovery.
Leadership Priorities
Build an experienced bench across business leadership, electromagnetics and systems engineering, regulatory and quality, clinical research, manufacturing, and commercialization.
Series A Funding Request
Milestone-based funding through pilot readiness. Allocation: 35% engineering + prototype · 20% testing + regulatory · 15% clinical + research · 12% software + data · 10% team + ops · 8% contingency.